Sebastiano Cimino

About

Dr. Sebastiano Cimino is a leading urologist whose research focuses on prostate cancer diagnostics, benign prostatic hyperplasia (BPH) surgery, and the impact of healthcare disruptions on urology training. His most influential work, cited 50 times, demonstrated that combining PHI and PCA3 biomarkers significantly improves the prognostic performance of PRIAS and Epstein criteria for identifying insignificant prostate cancer in men eligible for active surveillance—a critical advance for reducing overtreatment. In BPH surgery, his 2023 propensity-score matched comparison of en-bloc HoLEP versus robot-assisted simple prostatectomy (27 citations) provided key evidence on perioperative outcomes and short-term efficacy. Notably, his 2020 study on the COVID-19 pandemic’s forced remodulation of urology residency (22 citations) offered a prescient analysis of how clinical and learning activities could be restructured during crises, highlighting opportunities for positive change in medical education. Dr. Cimino’s work bridges precision diagnostics, surgical innovation, and adaptive training models, making him a versatile contributor to modern urology.

Research Focus

Key Achievements

Top Papers

1. 1
   PHI and PCA3 improve the prognostic performance of PRIAS and Epstein criteria in predicting insignificant prostate cancer in men eligible for active surveillance

   50 citations · 2015
2. 2
   Comparison of perioperative and short-terms outcomes of en-bloc Holmium laser enucleation of the prostate (HoLEP) and robot-assisted simple prostatectomy: a propensity-score matching analysis

   27 citations · 2023
3. 3
   How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency?

   22 citations · 2020

Key Collaborators

Contact & Links